| Financial Year |
March 31 2023 |
| Monetary Funds |
158,611,646,000.00 |
| Held-for-trading Financial Assets |
1,047,871,000.00 |
| Notes Receivable |
7,075,110,000.00 |
| Accounts Receivable |
162,072,769,000.00 |
| Advances to Suppliers |
31,329,099,000.00 |
| Other Receivables |
66,775,777,000.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
212,292,000.00 |
| Dividend Receivable |
953,661,000.00 |
| Inventories |
311,073,327,000.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
24,353,205,000.00 |
| Other Current Assets |
27,396,590,000.00 |
| Total Current Assets |
1,062,116,266,000.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
82,085,075,000.00 |
| Long-term Equity Investment |
130,841,835,000.00 |
| Investment Properties |
9,810,392,000.00 |
| Fixed Assetes |
66,447,061,000.00 |
| Under-construction Projects |
8,227,872,000.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
63,169,766,000.00 |
| R&D expenses |
42,654,000.00 |
| Goodwill |
164,345,000.00 |
| Long-Term Deferred and Prepaid Expenses |
830,024,000.00 |
| Deferred Income Tax Assets |
9,472,145,000.00 |
| Other Non-Current Assets |
114,508,549,000.00 |
| Sub-Total of Non-Current Assets |
529,630,774,000.00 |
| Total Assets |
1,591,747,040,000.00 |
| Short-Term Loans |
89,826,931,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
83,363,541,000.00 |
| Accounts Payable |
428,318,596,000.00 |
| Accounts Received In Advance |
384,654,000.00 |
| Employee Compensation Payable |
12,001,154,000.00 |
| Taxes Payable |
7,391,061,000.00 |
| Interest Payable |
89,416,000.00 |
| Dividend Payable |
1,452,277,000.00 |
| Other payables |
107,911,618,000.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
42,583,908,000.00 |
| Other Current Liabilities |
31,810,577,000.00 |
| Sub-Total of Current Liabilities |
975,022,847,000.00 |
| Long-term Loans |
148,715,408,000.00 |
| Bonds Payable |
33,079,609,000.00 |
| Long-Term Accounts Payable |
37,185,803,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,212,260,000.00 |
| Deferred Income Tax Liabilities |
1,684,379,000.00 |
| Other Non-Current Liabilities |
711,487,000.00 |
| Sub-Total of Non-Current Liabilities |
226,561,470,000.00 |
| Total Liabilities |
1,201,584,317,000.00 |
| Paid-In Capital(Or Share Stock) |
13,579,542,000.00 |
| Capital Surplus |
48,904,054,000.00 |
| Surplus Reserve |
6,789,771,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
167,353,472,000.00 |
| Minority Stockholder's Interest |
94,627,654,000.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
295,535,069,000.00 |
| Owner's Equity（Stockholder's Equity） |
390,162,723,000.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,591,747,040,000.00 |
